Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Ph III study to evaluate the safety of ALN-TTR02 in TTR-Medicated Polyneuropathy
Clinical Trial Grant
Duke Scholars
Principal Investigator
Yubin Kang
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Alnylam Pharmaceuticals
Start Date
November 1, 2014
End Date
August 2, 2018
Awarded By
Alnylam Pharmaceuticals
Start Date
November 1, 2014
End Date
August 2, 2018
